CV Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

The following summarizes activity related to the Company's stock options and includes 7,250,000 options issued prior to December 31, 2018 outside of the 2013 Plan (in thousands, except per share data):



	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contract Term (in years)	Aggregate Intrinsic Value
Outstanding - December 31, 2018	24,775	$	0.51	7.5	$	94,206
Granted	1,805	4.42		—	—
Exercised	(821)	0.36		—	—
Forfeited	(141)	0.82		—	—
Expired	—	—		—	—
Outstanding - June 30, 2019	25,618	0.79		6.4	85,035

Exercisable - June 30, 2019	22,624	0.53		6.1	80,242
Vested or expected to vest - June 30, 2019	25,618	$	0.79	6.4	$	85,035

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table presents the weighted average grant date fair value of stock options granted and the weighted-average assumptions used to estimate the fair value on the date of grant using the Black-Scholes valuation model:



	Three months ended June 30,		Six months ended June 30,
	2019	2018⁽¹⁾	2019	2018
Volatility	110.9%	—%	113.8%	90.5%
Risk-Free Interest Rate	1.8%	—%	2.5%	2.6%
Expected Term (in years)	5.80	0.00	5.70	5.40
Dividend Rate	—%	—%	—%	—	%
Fair Value Per Share on Grant Date	$3.31	$—	$4.00	$0.30
(1) There were no option grants during the three months ended June 30, 2018.

Nonvested Stock Option Activity

The following summarizes RSU activity that contain only service requirements to vest for the Amended 2013 Plan (in thousands, except per share data):



	Number of Shares		Weighted Average Grant Date Fair Value
RSU's outstanding - December 31, 2018	2,950		$	2.14
Granted	—		—
Vested	(2,950	)	2.14
Cancellations	—		—
RSU's outstanding - June 30, 2019	—		$	—